In the midst of marijuana laws changing quickly across the United States, Pennsylvania has become the first state to permit medical marijuana research at some of its medical schools.
On Thursday, the Department of Health released the guidelines opening applications for medical research. Penn Medicine, Drexel University, and the University of the Sciences have all expressed interest in furthering medical marijuana research, according to NBC10.
“We believe that the research will be of great importance in determining the safety and efficacy of medical cannabis products in treating specific diseases,” the University of Pittsburgh wrote in a statement to NBC10.
Although Ohio and Florida have also looked into similar facets in their medical marijuana programs, neither state has yet to implement such a program, reported NBC10.
Up to eight medical schools could be granted approval for this research program. The state will begin to accept applications next month.
The Department of Health also announced the addition of 13 new medical marijuana growers and 23 new dispensaries in the state. The approved schools will work with authorized growers and dispensers to obtain marijuana for research. [Read more at The Daily Pennsylvanian]
Your email address will not be published. Required fields are marked *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
Comment *
Notify me of follow-up comments by email.
Notify me of new posts by email.
Δ
Founded in 2018, Michigan-based C3 Industries is a privately owned, vertically integrated cannabis company that has in short order expanded its retail, cultivation, and manufacturing operations from one state to…
By Aaron Pelley, Attorney at Harris Sliwoski The fluctuating levels of reported THC (tetrahydrocannabinol) in cannabis products have sparked discussions and concerns within the industry. Contrary to popular belief, the…
The Biden administration is expected to reclassify the federal government’s position on marijuana, shifting it from a Schedule I drug to a Schedule III drug, The Associated Press first reported. The change would…
As the Biden administration moves to reclassify marijuana as a less dangerous drug, scientists say the change will lift some of the restrictions on studying the drug. But the change…